MBOT Microbot Medical Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: MBOT

Price (delayed)

$1.71

Market cap

$114.85M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.26

Enterprise value

$111.83M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 9

Microbot Medical Inc. is a pre-clinical medical device company that specializes in transformational micro-robotic technologies, focused primarily on both natural and artificial lumens within the human body. Microbot's current proprietary ...

Highlights
Microbot Medical's EPS has surged by 60% YoY and by 10% QoQ
The equity has soared by 156% YoY but it has decreased by 4.4% QoQ
MBOT's quick ratio is up by 35% YoY but it is down by 5% from the previous quarter
MBOT's net income is down by 22% year-on-year and by 8% since the previous quarter
Microbot Medical's debt has increased by 3.8% from the previous quarter
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.microbotmedical.com

Key stats

What are the main financial stats of MBOT

MBOT stock price

How has the Microbot Medical stock price performed over time
Intraday
-2.84%
1 week
-2.29%
1 month
-4.47%
1 year
-37.59%
YTD
-14.5%
QTD
-12.31%

Financial performance

How have Microbot Medical's revenue and profit performed over time
Revenue
$105,000
Gross profit
$2,000
Operating income
-$15.73M
Net income
-$14.21M
Gross margin
1.9%
Net margin
-13,535.2%
MBOT's operating income is down by 28% year-on-year and by 9% since the previous quarter
MBOT's net income is down by 22% year-on-year and by 8% since the previous quarter

Price vs fundamentals

How does MBOT's price correlate with its fundamentals

Growth

What is Microbot Medical's growth rate over time

Valuation

What is Microbot Medical stock price valuation
P/E
N/A
P/B
1.55
P/S
1,093.72
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1,065.07
Microbot Medical's EPS has surged by 60% YoY and by 10% QoQ
The equity has soared by 156% YoY but it has decreased by 4.4% QoQ
The stock's price to book (P/B) is 52% less than its 5-year quarterly average of 3.2 and 30% less than its last 4 quarters average of 2.2

Efficiency

How efficient is Microbot Medical business performance
The company's return on invested capital has surged by 83% YoY and by 12% QoQ
The ROE has soared by 80% YoY and by 11% from the previous quarter
MBOT's return on assets has surged by 78% year-on-year and by 10% since the previous quarter

Dividends

What is MBOT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MBOT.

Financial health

How did Microbot Medical financials performed over time
The total assets has soared by 153% YoY but it fell by 4.3% QoQ
MBOT's total liabilities has surged by 104% year-on-year
Microbot Medical's debt is 99% less than its equity
The equity has soared by 156% YoY but it has decreased by 4.4% QoQ
Microbot Medical's debt has increased by 3.8% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.